TY  - JOUR
AU  - Molina-Vega, Maria
AU  - Picon-Ccsar, Maria J
AU  - Gutierrez-Repiso, Carolina
AU  - Fernandez-Valero, Andrea
AU  - Lima-Rubio, Fuensanta
AU  - Gonzalez-Romero, Stella
AU  - Moreno-Indias, Isabel
AU  - Tinahones, Francisco J
PY  - 2021
DO  - 10.1016/j.biopha.2021.112465
UR  - http://hdl.handle.net/10668/22038
T2  - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
AB  - Metformin, which is known to produce profound changes in gut microbiota, is being increasingly used in gestational diabetes mellitus (GDM). The aim of this study was to elucidate the differences in gut microbiota composition and function in women with...
LA  - en
PB  - Elsevier
KW  - Gestational diabetes
KW  - Gut microbiota
KW  - Insulin
KW  - Metabolic control
KW  - Metformin
KW  - Weight gain
KW  - Adult
KW  - Body Mass Index
KW  - Diabetes, Gestational
KW  - Female
KW  - Gastrointestinal Microbiome
KW  - Glycemic Control
KW  - Humans
KW  - Hypoglycemia
KW  - Hypoglycemic Agents
KW  - Insulin
KW  - Metformin
KW  - Pregnancy
KW  - RNA, Ribosomal, 16S
KW  - Treatment Outcome
KW  - Weight Gain
TI  - Metformin action over gut microbiota is related to weight and glycemic control in gestational diabetes mellitus: A randomized trial.
TY  - research article
VL  - 145
ER  -